Login
$DNLI
$18.66 +$0.25 (1.36%) Close

$DNLI SEC Filings

Filed On Filing
09 Sep 2026 Form 4: Chin Peter Scott, Chief Medical Officer

Sold 1,654 shares ($36.9K)

04 Sep 2026 144
04 Sep 2026 Form 4: Thornberry Nancy, Director

Sold 11,439 shares ($262K)

03 Sep 2026 Form 4: Schuth Alexander O., COFO and Secretary

Sold 2,768 shares ($64.9K)

02 Sep 2026 144
01 Sep 2026 144
14 Aug 2026 Form 4: Watts Ryan J., Director

Gave 32,220 shares as a gift

13 Aug 2026 Form 4: Schuth Alexander O., COFO and Secretary

Sold 2,857 shares ($71.6K)

11 Aug 2026 144
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition
04 Aug 2026 SCHEDULE 13G/A
28 Jul 2026 8-K: Completion of Acquisition or Disposition of Assets
08 Jul 2026 SCHEDULE 13G/A
18 Jun 2026 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
05 Jun 2026 Form 4: Flatley Jay T, Director

Received 6,408 shares as a grant or award · Granted 19,226 Stock Option (right to buy)

05 Jun 2026 Form 4: Klein Peter S, Director

Received 6,408 shares as a grant or award · Granted 19,226 Stock Option (right to buy)

05 Jun 2026 Form 4: Krognes Steve E., Director

Received 6,408 shares as a grant or award · Granted 19,226 Stock Option (right to buy)

05 Jun 2026 Form 4: Schenkein David P, Director

Received 6,408 shares as a grant or award · Granted 19,226 Stock Option (right to buy)

05 Jun 2026 Form 4: Thornberry Nancy, Director

Received 6,408 shares as a grant or award · Granted 19,226 Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support